Pharma Pulse 8/27/24: The Clinical and Economic Impact of Care, Capabilities of a 3PL Provider & more

The Capabilities of a 3PL Provider

Chris Williams expands on the services that a third-party logistics (3PL) partner should offer, while sharing ways to alleviate standard supply chain issues.

Navigating the Complexities of NSCLC Treatment: The Clinical and Economic Impact of Care

The financial burden has increased significantly since 2015.

Inside Universities’ Love-Hate Relationship With ChatGPT

OpenAI continues to expand some of its educational offerings, while holding others—including a tool that could be used to detect cheating—back.

Reliance Rx Partners with Waltz Health to Lower Costs of Specialty Medications

Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, and specialty pharmacy leader Reliance Rx announced a partnership to lower the cost of prescription specialty drugs. Reliance Rx joins Waltz Health’s Waltz Connect program as an in-network option for all specialty medications.

Dan Rizzo on LinkedIn

It was great to sit down with Pharmaceutical Executive to share the latest #VeevaPulse findings. Now that we understand more about pre-launch investment in scientific outreach, we can quantify the impact of targeted #medicalaffairs strategies on treatment adoption. Plus, we also found that with early-career experts more open to digital, they are four times more likely to start patients on a new treatment.

Check out the piece (https://lnkd.in/gCVu83Qj). Thank you Pharmaceutical Executive for having me.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs